These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 15623595)

  • 1. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
    Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
    Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis.
    Xi S; Dyer KF; Kimak M; Zhang Q; Gooding WE; Chaillet JR; Chai RL; Ferrell RE; Zamboni B; Hunt J; Grandis JR
    J Natl Cancer Inst; 2006 Feb; 98(3):181-9. PubMed ID: 16449678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
    Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
    Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic abnormalities associated with chemoradiation resistance of head and neck squamous cell carcinoma.
    van den Broek GB; Wreesmann VB; van den Brekel MW; Rasch CR; Balm AJ; Rao PH
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4386-91. PubMed ID: 17671120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis.
    Squire JA; Bayani J; Luk C; Unwin L; Tokunaga J; MacMillan C; Irish J; Brown D; Gullane P; Kamel-Reid S
    Head Neck; 2002 Sep; 24(9):874-87. PubMed ID: 12211052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma.
    Hasegawa Y; Goto M; Hanai N; Ijichi K; Terada A; Hyodo I; Ogawa T; Fukushima M
    Oncology; 2007; 73(1-2):104-11. PubMed ID: 18337622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of S100A2 in lymph node metastases of head and neck cancer.
    Zhang X; Hunt JL; Shin DM; Chen ZG
    Head Neck; 2007 Mar; 29(3):236-43. PubMed ID: 17123307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
    Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
    Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
    Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
    Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.
    Bradford CR; Zhu S; Ogawa H; Ogawa T; Ubell M; Narayan A; Johnson G; Wolf GT; Fisher SG; Carey TE
    Head Neck; 2003 Aug; 25(8):654-61. PubMed ID: 12884349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
    J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of cyclin D1 correlates with sensitivity to cisplatin in squamous cell carcinoma cell lines of the head and neck.
    Akervall J; Kurnit DM; Adams M; Zhu S; Fisher SG; Bradford CR; Carey TE
    Acta Otolaryngol; 2004 Sep; 124(7):851-7. PubMed ID: 15484403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectral karyotyping analysis of head and neck squamous cell carcinoma.
    Singh B; Gogineni S; Goberdhan A; Sacks P; Shaha A; Shah J; Rao P
    Laryngoscope; 2001 Sep; 111(9):1545-50. PubMed ID: 11568603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
    Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
    Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
    Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
    J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.
    Myers JN; Yasumura S; Suminami Y; Hirabayashi H; Lin Wc; Johnson JT; Lotze MT; Whiteside TL
    Clin Cancer Res; 1996 Jan; 2(1):127-35. PubMed ID: 9816099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
    Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene profiling in squamous cell carcinoma of the head and neck.
    Akervall J
    Cancer Metastasis Rev; 2005 Jan; 24(1):87-94. PubMed ID: 15785874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.